Abstract
We explored the emergence of disparities in COVID-19 testing and outcomes in NYC and Philadelphia, two large US cities at two different stages of the epidemic. We used zip code-level data from the NYC Department of Health and Mental Hygiene and the Philadelphia Department of Public Health. We linked this data to a deprivation index calculated using 2014-2018 American Community Survey data. We have documented a dynamic situation regarding disparities in COVID-19 testing in two US cities. There are wide disparities in testing availability for the most deprived neighborhoods in Philadelphia, a city early in the epidemic, while these disparities seemingly dissipated in NYC, a city with more widespread testing later in the epidemic. However, we consistently see a very strong positive correlation with the % of tests that are positive in both cities, and this disparity is widening over time.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
UB was supported by the Office of the Director of the National Institutes of Health under award number DP5OD26429. The funding agencies had no involvement in the study design; in the data collection, analyses or interpretation of data; in the writing of this work; or in the decision to submit the manuscript for publication.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data is publicly available. Code is available on a github repository.
